Cancer in HIV-infected persons from the caribbean, central and South America

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 5, 2011, Pages 467-473

  Fink, Valeria I ^a,j   Shepherd, Bryan E ^b   Cesar, Carina ^a   Krolewiecki, Alejandro ^a   Wehbe, Firas ^b   Cortés, Claudia P ^c   Ramírez, Brenda Crabtree ^d   Padgett, Denis ^e   Shafaee, Maryam ^f   Schechter, Mauro ^g   Gotuzzo, Eduardo ^h   Bacon, Melanie ⁱ   McGowan, Catherine ^b   Cahn, Pedro ^a   Masys, Daniel ^b  

^a FUNDACIÓN HUÉSPED   (Argentina)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF CHILE   (Chile)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e Inst Hondureno de Seguridad Social   (Honduras)

^f Department of Obstetrics Gynecology   (United States)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

ⁱ DAIDS Epidemiology   (United States)

^j Pasaje Peluffo 3932   (Argentina)

more..

Author keywords

Caribbean; cohort studies; HIV; Latin America; neoplasms

Indexed keywords

ADULT; ANUS CANCER; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CARIBBEAN ISLANDS; CENTRAL AMERICA; CYTOLOGY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; NEOPLASM; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; SKIN CANCER; SOUTH AMERICA; TESTIS CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 79953042829     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31820bb1c3     Document Type: Article

References (42)

1. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67. (Pubitemid 47017468)
2. Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16: 405-408. (Pubitemid 46548641)
3. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745. (Pubitemid 32259908)
4. Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962-972. (Pubitemid 47073502)
5. CDC, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992 41 961-962.
6. Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121-130. (Pubitemid 40347381)
7. Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol. 2006;18:469-478. (Pubitemid 44199843)
8. Grulich AE. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS. 2009;4:183-187.
9. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143-1153. (Pubitemid 47233717)
10. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148:728-736. (Pubitemid 351717418)
11. ONUSIDA, América Latina, Ú ltimas tendencias epidemiológicas, Hoja de Datos. Available at: http://data.unaids.org/pub/ FactSheet/2009/20091124-FS-latinamerica-es.pdf. Accessed May 10, 2010.
12. ONUSIDA, Caribe, Ú ltimas tendencias epidemiológicas, Hoja de Datos. Available at: http://data.unaids.org/pub/FactSheet/2009/20091124-FS- caribbean-es.pdf. Accessed May10, 2010.
13. UNAIDS. The global AIDS epidemic, Global Facts & Figures. Available at: http://data.unaids.org/pub/FactSheet/2009/20091124-FS-global-en.pdf. Accessed 10 May 2010.
14. WHO. Towards universal access scaling up priority HIV/AIDS interventions in the health sector 2009 Progress Report. 2009. Available at http://www.who.int/hiv/pub/2009progressreport/en/index.html. Accessed May 06, 2010.
15. PAHO. PAHO plan of action for cancer prevention & control: cancer stakeholders meeting, fact sheet: cancer in Latin America and the Caribbean. Available at http://www.paho.org/english/ad/dpc/nc/pcc-fact-sheet-LAC.pdf. Accessed May 06, 2010.
16. Bacchi CE, Bacchi MM, Rabenhorst SH, et al. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus. Am J Clin Pathol. 1996;105:230-237. (Pubitemid 26047486)
17. Collins JA, Hernandez AV, Hidalgo JA, et al. High proportion of T-cell systemic non-Hodgkin lymphoma in HIV-infected patients in Lima, Peru. J Acquir Immune Defic Syndr. 2005;40:558-564. (Pubitemid 41669160)
18. Ferrera A, Melchers WJ, Velema JP, et al. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras. Am J Trop Med Hyg. 1997;57:138-141. (Pubitemid 27360601)
19. Fink V, Cesar C, Ameri D, et al. Tumores y HIVen un centro de referencia de Buenos Aires: 5 años de experiencia. Actualizaciones en SIDA. 2009; 17(Suppl 1):64-75.
20. Laurido M, Uruena A, Vizzotti C, et al. Incidence variation in malignancies associated or not with AIDS at an outpatient care center, 1997-2005 [In Spanish]. Medicina (B Aires). 2007;67:243-246. (Pubitemid 47062438)
21. Osorio SG, Montenegro UC. Linfomas asociados a infección por virus de inmunodeficiencia humana en un complejo hospitalario de la Región Metropolitana, Chile: 1990-2002. Reporte de 14 casos y revisión. Rev Chil Infect. 2007;24:117-124.
22. Sampaio J, Brites C, Araujo I, et al. AIDS related malignancies in Brazil. Curr Opin Oncol. 2007;19:476-478. (Pubitemid 47356605)
23. McGowan CC, Cahn P, Gotuzzo E, et al. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007;36: 969-976. (Pubitemid 350018541)
24. Tuboi SH, Schechter M, McGowan CC, et al. Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr. 2009;51:615-623.
25. Cesar C, Shepherd BE, Krolewiecki AJ, et al. Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS One. 2010;5:e10490.
26. Schafer J, ed. Analysis of Incomplete Multivariate Data. London, United Kingdom Chapman & Hall 1997.
27. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97: 425-432. (Pubitemid 40528605)
28. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20: 1645-1654. (Pubitemid 44162407)
29. Galceran J, Marcos-Gragera R, Soler M, et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer. 2007;43:1085-1091. (Pubitemid 46505101)
30. Krishnan A, Levine AM. Malignancies in women with HIV infection. Womens Health (Lond Engl). 2008;4:357-368.
31. Long JL, Engels EA, Moore RD, et al. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008;22:489-496. (Pubitemid 351317290)
32. Burgi A, Brodine S, Wegner S, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005;104:1505-1511. (Pubitemid 41356166)
33. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009;27:884-890.
34. Kiely B, O'Flaherty J, Surah S, et al. HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre. Int J STD AIDS. 2010;21:332-336.
35. Palefsky J. Human papillomavirus infection in HIV-infected persons. To p HIV Med. 2007;15:130-133.
36. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97:577-586. (Pubitemid 40723785)
37. PAHO. Estrategia y plan de acción regionales sobre la prevención y el control del cáncer cervocouterino. 142.a SESIÓN DEL COMITÉ EJECUTIVO. Available at http://www.paho.org/ spanish/gov/ce/ce142-10-s.pdf Accessed June 22, 2010.
38. Ferenczy A, Coutlee F, Franco E, et al. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ. 2003;169:431-434. (Pubitemid 37076256)
39. Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009;23:41-50.
40. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis. 2004;39:1380-1384. (Pubitemid 39458526)
41. Mocroft A, Sterne JA, Egger M, et al. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis. 2009;48:1138-1151.
42. Serraino D, De Paoli A, Zucchetto A, et al. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era. Cancer Epidemiol. 2010;34: 257-261.